DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
French Adjuvant Study Group.
Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial.
J Clin Oncol 2001;
19: 602-611
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.